Ophthalmology

Top Story

Survey: Sustained-release dexamethasone insert earns high satisfaction rating from cataract patients

March 24, 2017

Subjective quality assessment of a sustained-release dexamethasone intracanalicular insert showed a high degree of patient satisfaction regarding comfort, convenience and pain control.

The insert, Dextenza by Ocular Therapeutix, was used as an alternative to postoperative topical corticosteroids in two phase 3 randomized, controlled, multicenter trials in patients undergoing cataract surgery. Efficacy in reducing inflammation and postoperative pain was demonstrated.

GOP, Trump pull AHCA due to lack of support

March 24, 2017
Reportedly acting on orders from President Donald J. Trump, House Republican leaders today again postponed a vote that would have overhauled the nation’s health…

Second Sight posts $33.2 million net loss in 2016

March 24, 2017
Second Sight Medical Products reported a net loss of $33.2 million, or $0.84 per share, in 2016 compared with a net loss of $20 million, or $0.56 per share, the previous…

ACP: Fight to stop AHCA not over

March 24, 2017
With the postponement of the House of Representatives vote on the American Health Care Act, the ACP urged Congress to reject the bill and start over in order to develop…

Nemus, Nanomerics to develop ocular formulation for glaucoma treatment

March 24, 2017
Nemus Bioscience and Nanomerics have signed a development agreement to develop a topical ocular formulation of tetrahydracannabinol-valine-hemisuccinate, according to a…
More News Headlines »
Original Article

Primary and Secondary Intraocular Lens Implantations in Children With Pediatric Cataract: Visual Acuity and Strabismus at the Age of 2 Years and Older

Journal of Pediatric Ophthalmology and Strabismus, March/April 2017, Volume 54 Issue 2
To compare the visual outcomes of primary and secondary intraocular lens (IOL) implantations and to identify the risk…
More »
CME

Best of Retina Forum® 2016 - Diabetic Retinopathy: A Revolution in Treatment Options

This activity is supported by educational grants from Carl Zeiss Meditec, Inc. and Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy (DR) is an insidious, progressive disease. Diabetic macular edema (DME), which can occur at any…
More »
Featured
World Retina Congress

World Retina Congress

From OSN Europe Video
Meeting News

VIDEO: Surgeon speaks about the advantages of CAPSULaser in cataract surgery

February 23, 2017
More »
Advertisement
Advertisement